{"entity":{"type":"insider","cik":"0001674099","url":"/insider/0001674099","json_url":"/insider/0001674099.json","name":"Longitude Venture Partners III, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":11,"first":"2018-09-25","last":"2022-04-21","span_basis":"filed_date"},"name_variants":[{"name":"Longitude Venture Partners III, L.P.","source":"filing","n_filings":11,"first_seen":"2018-09-25","last_seen":"2022-04-21"}],"transactions":[{"id":6691184,"accession":"0000899243-22-015325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015325","line_url":"/filing/0000899243-22-015325#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Venture Partners III, L.P.; Longitude Capital Partners III, LLC; ENRIGHT PATRICK G; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1355000.0,"shares_display":"1,355,000","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":4999950.0,"total_display":"4,999,950.00","shares_owned_after":4174379.0,"shares_owned_after_display":"4,174,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-21","scope":"insider"},{"id":6531980,"accession":"0000899243-22-004271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-004271","line_url":"/filing/0000899243-22-004271#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Prime Fund, L.P.; Longitude Prime Partners, LLC; ENRIGHT PATRICK G; Tammenoms Bakker Juliet; Longitude Venture Partners III, L.P.; Longitude Capital Partners III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":4725000.0,"total_display":"4,725,000.00","shares_owned_after":175000.0,"shares_owned_after_display":"175,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-02","scope":"insider"},{"id":4708239,"accession":"0000899243-21-019166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-019166","line_url":"/filing/0000899243-21-019166#line-2","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners III, LLC; ENRIGHT PATRICK G; Longitude Venture Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":235000.0,"shares_display":"235,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3995000.0,"total_display":"3,995,000.00","shares_owned_after":3220775.0,"shares_owned_after_display":"3,220,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-11","scope":"insider"},{"id":3239630,"accession":"0000899243-20-023790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-023790","line_url":"/filing/0000899243-20-023790#line-2","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners III, LLC; Longitude Venture Partners III, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2447.0,"shares_display":"2,447","price_per_share":10.7461,"price_display":"10.75","price_state":"stated","total_value":26295.7067,"total_display":"26,295.71","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider"},{"id":3239625,"accession":"0000899243-20-023790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-023790","line_url":"/filing/0000899243-20-023790#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners III, LLC; Longitude Venture Partners III, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1049.0,"shares_display":"1,049","price_per_share":10.7461,"price_display":"10.75","price_state":"stated","total_value":11272.6589,"total_display":"11,272.66","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider"},{"id":2101106,"accession":"0000899243-20-020572","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-020572","line_url":"/filing/0000899243-20-020572#line-3","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Venture Partners III, L.P.; Tammenoms Bakker Juliet; ENRIGHT PATRICK G; Longitude Capital Partners III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":2819379.0,"shares_owned_after_display":"2,819,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-28","scope":"insider"},{"id":3111754,"accession":"0000899243-20-019123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-019123","line_url":"/filing/0000899243-20-019123#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Venture Partners III, L.P.; Longitude Capital Partners III, LLC; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":109090.0,"shares_display":"109,090","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":2999975.0,"total_display":"2,999,975.00","shares_owned_after":2600877.0,"shares_owned_after_display":"2,600,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-14","scope":"insider"},{"id":9204689,"accession":"0000899243-19-028574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028574","line_url":"/filing/0000899243-19-028574#line-1","is_derivative":false,"issuer_cik":"0001674099","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001674099","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners III, LLC; Longitude Venture Partners III, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":937500.0,"shares_display":"937,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","shares_owned_after":4199035.0,"shares_owned_after_display":"4,199,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-12-05","scope":"insider"},{"id":7967368,"accession":"0000899243-19-028242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028242","line_url":"/filing/0000899243-19-028242#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"Longitude Venture Partners III, L.P.; Longitude Capital Partners III, LLC; Tammenoms Bakker Juliet; ENRIGHT PATRICK G","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":937000.0,"shares_display":"937,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":7496000.0,"total_display":"7,496,000.00","shares_owned_after":4198535.0,"shares_owned_after_display":"4,198,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider"},{"id":7939022,"accession":"0000899243-19-027219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027219","line_url":"/filing/0000899243-19-027219#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Capital Partners III, LLC; ENRIGHT PATRICK G; Tammenoms Bakker Juliet; Longitude Venture Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":575000.0,"shares_display":"575,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":9200000.0,"total_display":"9,200,000.00","shares_owned_after":575000.0,"shares_owned_after_display":"575,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-13","scope":"insider"},{"id":5981355,"accession":"0000899243-18-028081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-028081","line_url":"/filing/0000899243-18-028081#line-2","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Axonics Modulation Technologies, Inc.","issuer_ticker":"AXNX","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Venture Partners III, L.P.; Longitude Capital Partners III, LLC; ENRIGHT PATRICK G","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":533333.0,"shares_display":"533,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":7999995.0,"total_display":"7,999,995.00","shares_owned_after":2933333.0,"shares_owned_after_display":"2,933,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-02","scope":"insider"},{"id":6021204,"accession":"0001209191-18-052151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-052151","line_url":"/filing/0001209191-18-052151#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"Longitude Capital Partners III, LLC; ENRIGHT PATRICK G; Tammenoms Bakker Juliet; Longitude Venture Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":365000.0,"shares_display":"365,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":2007500.0,"total_display":"2,007,500.00","shares_owned_after":3261535.0,"shares_owned_after_display":"3,261,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-21","filed_date":"2018-09-25","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Ten percent owner","n_filings":2,"first_seen":"2020-07-28","last_seen":"2022-04-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Ten percent owner","n_filings":1,"first_seen":"2022-02-02","last_seen":"2022-02-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001827506","name":"Talaris Therapeutics, Inc.","url":"/issuer/0001827506","role":"Ten percent owner","n_filings":1,"first_seen":"2021-05-11","last_seen":"2021-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"Molecular Templates, Inc.","url":"/issuer/0001183765","role":"Ten percent owner","n_filings":4,"first_seen":"2018-09-25","last_seen":"2020-09-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Ten percent owner","n_filings":2,"first_seen":"2019-11-13","last_seen":"2020-07-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001603756","name":"Axonics Modulation Technologies, Inc.","url":"/issuer/0001603756","role":"Ten percent owner","n_filings":1,"first_seen":"2018-11-02","last_seen":"2018-11-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001674099","retrieved_at":"2026-08-21T13:56:15+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}